Alzamend Neuro, Inc. (ALZN) Financials
ALZN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-10-31 | 983597 | 3.7 million |
| 2023-07-31 | 2.6 million | 2.7 million |
| 2023-04-30 | 5.9 million | 2.9 million |
| 2023-01-31 | 8.5 million | 2.6 million |
ALZN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-10-31 | -1.5 million | 318336 |
| 2023-07-31 | -3.4 million | 369380 |
| 2023-04-30 | -2.2 million | 491326 |
| 2023-01-31 | -1.8 million | 1.5 million |
ALZN Net Income
No data available :(
ALZN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-10-31 | 200079 | - | - |
| 2023-07-31 | 1.7 million | - | - |
| 2023-04-30 | 5.1 million | - | - |
| 2023-01-31 | 7.4 million | - | - |
ALZN Shares Outstanding
ALZN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-10-31 | - | 2.0 million | 904939 | - |
| 2023-07-31 | 147243 | 2.4 million | 912460 | 247334 |
| 2023-04-30 | 147243 | 1.6 million | 1.4 million | 247334 |
| 2023-01-31 | 147243 | 2.9 million | 2.5 million | 247333 |
ALZN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-10-31 | - | 12685 |
| 2023-07-31 | - | 12685 |
| 2023-04-30 | - | 5323 |
| 2023-01-31 | - | 5323 |
ALZN
Price: $0.70
52 week price:
Earnings Per Share: -1.78 USD
P/E Ratio: -0.38
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 216306
Market Capitalization: 6.3 million